Logo image of ALPRI.PA

PRISMAFLEX INTERNATIONAL (ALPRI.PA) Stock Fundamental Analysis

EPA:ALPRI - Euronext Paris - Matif - FR0004044600 - Common Stock - Currency: EUR

7  +0.5 (+7.71%)

Fundamental Rating

3

Overall ALPRI gets a fundamental rating of 3 out of 10. We evaluated ALPRI against 61 industry peers in the Media industry. Both the profitability and financial health of ALPRI have multiple concerns. ALPRI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALPRI had positive earnings in the past year.
ALPRI had a positive operating cash flow in the past year.
In the past 5 years ALPRI reported 4 times negative net income.
ALPRI had a positive operating cash flow in each of the past 5 years.
ALPRI.PA Yearly Net Income VS EBIT VS OCF VS FCFALPRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

ALPRI's Return On Assets of 1.62% is in line compared to the rest of the industry. ALPRI outperforms 44.26% of its industry peers.
ALPRI has a Return On Equity of 6.50%. This is comparable to the rest of the industry: ALPRI outperforms 52.46% of its industry peers.
ALPRI has a Return On Invested Capital of 4.97%. This is comparable to the rest of the industry: ALPRI outperforms 44.26% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALPRI is significantly below the industry average of 8.60%.
The last Return On Invested Capital (4.97%) for ALPRI is above the 3 year average (2.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.62%
ROE 6.5%
ROIC 4.97%
ROA(3y)-1.41%
ROA(5y)-2.44%
ROE(3y)-8.14%
ROE(5y)-11.62%
ROIC(3y)2.68%
ROIC(5y)N/A
ALPRI.PA Yearly ROA, ROE, ROICALPRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ALPRI has a worse Profit Margin (1.21%) than 62.30% of its industry peers.
ALPRI has a worse Operating Margin (2.42%) than 63.93% of its industry peers.
The Gross Margin of ALPRI (36.31%) is worse than 67.21% of its industry peers.
In the last couple of years the Gross Margin of ALPRI has grown nicely.
Industry RankSector Rank
OM 2.42%
PM (TTM) 1.21%
GM 36.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.12%
GM growth 5Y4.02%
ALPRI.PA Yearly Profit, Operating, Gross MarginsALPRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALPRI is destroying value.
Compared to 1 year ago, ALPRI has about the same amount of shares outstanding.
Compared to 5 years ago, ALPRI has more shares outstanding
The debt/assets ratio for ALPRI is higher compared to a year ago.
ALPRI.PA Yearly Shares OutstandingALPRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALPRI.PA Yearly Total Debt VS Total AssetsALPRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.07 indicates that ALPRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALPRI has a Altman-Z score of 2.07. This is in the better half of the industry: ALPRI outperforms 72.13% of its industry peers.
ALPRI has a debt to FCF ratio of 6.95. This is a slightly negative value and a sign of low solvency as ALPRI would need 6.95 years to pay back of all of its debts.
ALPRI has a Debt to FCF ratio (6.95) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.76 indicates that ALPRI is somewhat dependend on debt financing.
ALPRI has a Debt to Equity ratio (0.76) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 6.95
Altman-Z 2.07
ROIC/WACC0.92
WACC5.41%
ALPRI.PA Yearly LT Debt VS Equity VS FCFALPRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

ALPRI has a Current Ratio of 1.28. This is a normal value and indicates that ALPRI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.28, ALPRI is doing good in the industry, outperforming 68.85% of the companies in the same industry.
ALPRI has a Quick Ratio of 1.28. This is a bad value and indicates that ALPRI is not financially healthy enough and could expect problems in meeting its short term obligations.
ALPRI has a Quick ratio (0.85) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.85
ALPRI.PA Yearly Current Assets VS Current LiabilitesALPRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.72% over the past year.
The Revenue has decreased by -5.40% in the past year.
The Revenue has been growing slightly by 1.20% on average over the past years.
EPS 1Y (TTM)42.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.62%
Revenue 1Y (TTM)-5.4%
Revenue growth 3Y9.22%
Revenue growth 5Y1.2%
Sales Q2Q%-3.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALPRI.PA Yearly Revenue VS EstimatesALPRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALPRI.PA Yearly EPS VS EstimatesALPRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 0 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.56 indicates a correct valuation of ALPRI.
The rest of the industry has a similar Price/Earnings ratio as ALPRI.
Compared to an average S&P500 Price/Earnings ratio of 24.12, ALPRI is valued a bit cheaper.
Industry RankSector Rank
PE 15.56
Fwd PE N/A
ALPRI.PA Price Earnings VS Forward Price EarningsALPRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

63.93% of the companies in the same industry are more expensive than ALPRI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALPRI is valued cheaper than 80.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.15
EV/EBITDA 5.45
ALPRI.PA Per share dataALPRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALPRI!.
Industry RankSector Rank
Dividend Yield N/A

PRISMAFLEX INTERNATIONAL

EPA:ALPRI (5/8/2025, 7:00:00 PM)

7

+0.5 (+7.71%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.52M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE N/A
P/S 0.19
P/FCF 5.15
P/OCF 2.92
P/B 1
P/tB 2.82
EV/EBITDA 5.45
EPS(TTM)0.45
EY6.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.36
FCFY19.42%
OCF(TTM)2.4
OCFY34.22%
SpS37.43
BVpS6.98
TBVpS2.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.62%
ROE 6.5%
ROCE 6.76%
ROIC 4.97%
ROICexc 5.98%
ROICexgc 10.03%
OM 2.42%
PM (TTM) 1.21%
GM 36.31%
FCFM 3.63%
ROA(3y)-1.41%
ROA(5y)-2.44%
ROE(3y)-8.14%
ROE(5y)-11.62%
ROIC(3y)2.68%
ROIC(5y)N/A
ROICexc(3y)3.15%
ROICexc(5y)N/A
ROICexgc(3y)4.8%
ROICexgc(5y)N/A
ROCE(3y)4.15%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.12%
GM growth 5Y4.02%
F-Score6
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 6.95
Debt/EBITDA 2.02
Cap/Depr 60.89%
Cap/Sales 2.77%
Interest Coverage 250
Cash Conversion 91.93%
Profit Quality 299.68%
Current Ratio 1.28
Quick Ratio 0.85
Altman-Z 2.07
F-Score6
WACC5.41%
ROIC/WACC0.92
Cap/Depr(3y)97.65%
Cap/Depr(5y)79.84%
Cap/Sales(3y)4.55%
Cap/Sales(5y)4.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.4%
Revenue growth 3Y9.22%
Revenue growth 5Y1.2%
Sales Q2Q%-3.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2981.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.94%
OCF growth 3Y168.18%
OCF growth 5YN/A